Clinical Trial Update: Obstructive Sleep Apnea (OSA) Treated With a Potassium Channel Inhibitor [Phase 2]

View source ↗

Summary

Phase 2 trial update for an obstructive sleep apnea treatment using a potassium channel inhibitor; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obstructive Sleep Apnea

Snippet

Sponsor: Bayer | Conditions: Sleep Apnea, Obstructive | Phase 2 | Status: COMPLETED